Form 483

Tekweld Solutions, Inc. Form 483, 2020-01-17

FDA issued a Form 483 to Tekweld Solutions, Inc. on 2020-01-17 with 5 public-safe observations.

483· Form 483 issuedHuman Drugs5 observations

Tekweld Solutions, Inc. · Hauppauge, United States · Issued January 17, 2020

Overview

  • 5 public-safe observations are available for this inspection.
  • 5 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

17 Jan 2020
21 CFR 211.122(a)

Written procedures describing in detail

Cited by Rachael A Moliver

17 Jan 2020
21 CFR 211.125(c)

Label reconciliation discrepancies evaluation/investigation

Cited by Rachael A Moliver

17 Jan 2020
21 CFR 211.130(e)

Packaging line inspection documentation

Cited by Rachael A Moliver

17 Jan 2020
21 CFR 211.22(a)

Lack of quality control unit

Cited by Rachael A Moliver

17 Jan 2020
21 CFR 211.25(a)

GMP Training Frequency

Cited by Rachael A Moliver

Inspected site

TSTekweld Solutions, Inc.Hauppauge, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.122(a)Cited across public-safe Form 483 observations1x
21 CFR 211.125(c)Cited across public-safe Form 483 observations1x
21 CFR 211.130(e)Cited across public-safe Form 483 observations1x
21 CFR 211.22(a)Cited across public-safe Form 483 observations1x
21 CFR 211.25(a)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 5 observations

The source PDF, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere